You just read:

Cognition Therapeutics to Highlight CT1812 Safety Data at the 9th Clinical Trials on Alzheimer's Disease (CTAD) Meeting

News provided by

Cognition Therapeutics, Inc. (CogRx)

05 Dec, 2016, 09:25 ET